1. The Impact of Aging on Cardio and Cerebrovascular Diseases
   Carmine Izzo et al, 2018, IJMS CrossRef
2. Prevention and treatment of hyperphosphatemia in chronic kidney disease
   Marc G. Vervloet et al, 2018, Kidney International CrossRef
3. The role of klotho in chronic kidney disease
   Di Zou et al, 2018, BMC Nephrol CrossRef
4. Fibroblast Growth Factor 23 and Klotho in AKI
   Marta Christov et al, 2019, Seminars in Nephrology CrossRef
5. Regulation of calcific vascular and valvular disease by nuclear receptors
   Tamer Sallam et al, 2019, Current Opinion in Lipidology CrossRef
6. Alpha‐Klotho, a critical protein for lung health, is not expressed in normal lung
   Jianning Zhang et al, 2019, FASEB BioAdvances CrossRef
7. FGF23 and Phosphate–Cardiovascular Toxins in CKD
   null Vogt et al, 2019, Toxins CrossRef
8. PPARγ and RhoBTB1 in hypertension
   Shi Fang et al, 2020, Current Opinion in Nephrology and Hypertension CrossRef
9. null
   Stefanos Roumeliotis et al, 2020 CrossRef
10. The Role of Sclerostin in Bone and Ectopic Calcification
    Annelies De Maré et al, 2020, IJMS CrossRef
11. Diabetes and Calcification: The Potential Role of Anti-Diabetic Drugs on Vascular Calcification Regression
    Sounak Ghosh et al, 2020, Pharmacological Research CrossRef
12. The Interplay of WNT and PPARγ Signaling in Vascular Calcification
    Stefan Reinhold et al, 2020, Cells CrossRef
13. Klotho Protein and Cardio-Vascular System
    Ivan N. Tyurenkov et al, 2021, Biochemistry Moscow CrossRef
14. Белок клото и сердечно-сосудистая система
    И.Н. Тюренков et al, 2021, БМ CrossRef
15. null
    Marc G. Vervloet et al, 2021 CrossRef
16. Roles of Nuclear Receptors in Vascular Calcification
    Giulia Chinetti et al, 2021, IJMS CrossRef
17. Correlation Between Soluble Klotho and Vascular Calcification in Chronic Kidney Disease: A Meta-Analysis and Systematic Review
    QiFeng Liu et al, 2021, Front. Physiol. CrossRef
18. Understanding the Stony Bridge between Osteoporosis and Vascular Calcification: Impact of the FGF23/Klotho axis
    Xu Wei et al, 2021, Oxidative Medicine and Cellular Longevity CrossRef
19. PPARγ and TGFβ—Major Regulators of Metabolism, Inflammation, and Fibrosis in the Lungs and Kidneys
    Gábor Kökény et al, 2021, IJMS CrossRef
20. null
    Maren Leifheit-Nestler et al, 2022 CrossRef
21. Pathobiology of the Klotho Antiaging Protein and Therapeutic Considerations
    Gérald J. Prud’homme et al, 2022, Front. Aging CrossRef
22. Regulatory and legal regulation of medical care in the «cosmetology» profile in the Russian Federation
    Alexey A. Kubanov et al, 2022, Medical Journal of the Russian Federation CrossRef
23. Klotho protein and atherosclerotic cardiovascular diseases: prolonging the thread of life
    Amina M. Alieva et al, 2022, Medical Journal of the Russian Federation CrossRef
24. Impact of PPAR-gamma activation on the durability of biological heart valve prostheses in hypercholesterolaemic rats
    Anna Kathrin Assmann et al, 2022 CrossRef
25. Upstream and downstream regulators of Klotho expression in chronic kidney disease
    Sha-Sha Li et al, 2023, Metabolism CrossRef
26. FGF23 and klotho at the intersection of kidney and cardiovascular disease
    Daniel Edmonston et al, 2023, Nat Rev Cardiol CrossRef
27. Emerging role of α-Klotho in energy metabolism and cardiometabolic diseases
    Yuanbin Liu et al, 2023, Diabetes & Metabolic Syndrome: Clinical Research & Reviews CrossRef
28. Klotho: a potential therapeutic target in aging and neurodegeneration beyond chronic kidney disease—a comprehensive review from the ERA CKD-MBD working group
    Mehmet Kanbay et al, 2024 CrossRef